The Development of Pulmonary Edema after Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patient; Neurogenic or Non-Neurogenic?

Recombinant tissue plasminogen activator (r-tPA) is the first-line drug for the treatment of acute ischemic stroke, despite it may lead to a variety of complications in some cases. In patients with extensive stroke, infarction of the brain can cause suppression of the respiratory center in the brain...

Descripción completa

Detalles Bibliográficos
Autores principales: Alwahdy, Ahmad Sulaiman, Sihombing, Ika Yulieta Margaretha, Alfina, Fitria Tahta, Syahdian, Niken, Nurbaeti, Putri, Futihandayani, Annisa, Ramadhanti, Allifka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Single Case − General Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459568/
https://www.ncbi.nlm.nih.gov/pubmed/36160659
http://dx.doi.org/10.1159/000526250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459568/
https://www.ncbi.nlm.nih.gov/pubmed/36160659
http://dx.doi.org/10.1159/000526250

Ejemplares similares